Atria Wealth Solutions Inc. Purchases 6,604 Shares of The Clorox Company (NYSE:CLX)

Atria Wealth Solutions Inc. boosted its position in shares of The Clorox Company (NYSE:CLXFree Report) by 24.6% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 33,456 shares of the company’s stock after purchasing an additional 6,604 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in Clorox were worth $5,434,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State Street Corp raised its holdings in Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after purchasing an additional 245,525 shares during the last quarter. Mizuho Securities USA LLC increased its stake in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after acquiring an additional 4,490,421 shares during the last quarter. Geode Capital Management LLC increased its stake in shares of Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after acquiring an additional 33,970 shares during the last quarter. Stifel Financial Corp increased its stake in shares of Clorox by 1.7% in the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after acquiring an additional 37,967 shares during the last quarter. Finally, Van ECK Associates Corp increased its stake in shares of Clorox by 2.2% in the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock valued at $237,372,000 after acquiring an additional 31,510 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Stock Up 1.8 %

Shares of NYSE CLX opened at $150.93 on Thursday. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The Clorox Company has a 52 week low of $127.60 and a 52 week high of $171.37. The stock has a market capitalization of $18.68 billion, a P/E ratio of 41.24, a PEG ratio of 2.53 and a beta of 0.42. The stock’s fifty day moving average is $158.38 and its 200 day moving average is $159.74.

Clorox (NYSE:CLXGet Free Report) last issued its quarterly earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the previous year, the company earned $2.16 EPS. Sell-side analysts forecast that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Analyst Ratings Changes

CLX has been the subject of a number of recent analyst reports. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and upped their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Evercore ISI increased their target price on Clorox from $145.00 to $155.00 in a research note on Tuesday, February 4th. JPMorgan Chase & Co. increased their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Finally, Royal Bank of Canada reissued a “sector perform” rating and set a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. Four research analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat.com, Clorox presently has an average rating of “Hold” and a consensus price target of $158.21.

Get Our Latest Stock Analysis on CLX

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.